Appointment of Ms. Chaitali Kalpataru Shah as a Executive Director and CFO of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma's board, at its meeting on July 16, 2025, approved the appointment of Ms. Chaitali Kalpataru Shah (DIN: 11167778) as Executive Director and Chief Financial Officer (CFO) with immediate effect. She brings experience in finance, accounts, corporate management, financial planning, reporting, and regulatory compliance. Concurrently, Mr. Jayesh Ramchandra Patil resigned from the CFO post due to personal reasons, also with immediate effect. His resignation letter indicates he had been with the company for around 18 years. The outgoing CFO's resignation was formally accepted by the board with appreciation for his service.
This is a routine leadership transition at a small-cap pharma company. The long-tenured outgoing CFO exits on personal grounds while a new CFO with finance and compliance expertise takes over, suggesting continuity in financial oversight with no apparent governance red flags.